Accelerated Manufacturing of mRNA Vaccines
Accelerated timelines are critical when responding to an outbreak and efficient vaccine manufacturing is required to enable a quicker transition from research to the clinic, saving lives. mRNAs allow biotechnology companies to develop vaccines in response to pandemics, such as COVID-19, in a matter of weeks.
Download this guide to learn more about:
- How mRNA vaccines work
- The benefits of mRNA capping
- Traditional vs novel capping methods
